Application of Nab-paclitaxel combined with gemcitabine in neoadjuvant chemotherapy laparoscopic followed by pancreatoduodenectomy to a patient with pancreas head cancer invading to protal vein
| Published in: | Asian Journal of Surgery |
|---|---|
| Main Authors: | Chunyan Li, Boyuan Huang, Yuke Yan, Xiaojun Yang |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-11-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S101595842200656X |
Similar Items
Camrelizumab Combined With Gemcitabine and Albumin-Bound Paclitaxel for Neoadjuvant Therapy in the Treatment of Progressive Gallbladder Cancer: A Case Report
by: Jing Wu, et al.
Published: (2022-03-01)
by: Jing Wu, et al.
Published: (2022-03-01)
Neoadjuvant‐modified FOLFIRINOX vs nab‐paclitaxel plus gemcitabine for borderline resectable or locally advanced pancreatic cancer patients who achieved surgical resection
by: Adam R. Wolfe, et al.
Published: (2020-07-01)
by: Adam R. Wolfe, et al.
Published: (2020-07-01)
Intensified Neoadjuvant Chemotherapy with Nab-Paclitaxel plus Gemcitabine Followed by FOLFIRINOX in a Patient with Locally Advanced Unresectable Pancreatic Cancer
by: Volker Kunzmann, et al.
Published: (2014-09-01)
by: Volker Kunzmann, et al.
Published: (2014-09-01)
Impact of pathological complete response following neoadjuvant chemotherapy (gemcitabine, nab-paclitaxel, S-1) and radiation for borderline resectable pancreatic cancer: a case report and review of literature
by: Mitsuru Kinoshita, et al.
Published: (2022-09-01)
by: Mitsuru Kinoshita, et al.
Published: (2022-09-01)
The efficiency of liposomal paclitaxel versus docetaxel in neoadjuvant chemotherapy with the TPF regimen for locally advanced nasopharyngeal carcinoma: a retrospective study
by: Zhi Yang, et al.
Published: (2024-10-01)
by: Zhi Yang, et al.
Published: (2024-10-01)
Phase 2 study of preoperative chemotherapy with nab‐paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node‐positive pancreatic ductal adenocarcinoma
by: Emerson Y. Chen, et al.
Published: (2023-06-01)
by: Emerson Y. Chen, et al.
Published: (2023-06-01)
A Retrospective Study of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
by: Wang Y, et al.
Published: (2020-09-01)
by: Wang Y, et al.
Published: (2020-09-01)
Neoadjuvant Doxorubicin-Paclitaxel Combined Chemotherapy in Patients with Inoperable Stage III Breast Cancer: A Retrospective Cohort Study with 10 Years of Follow-Up in Vietnam
by: Duc Thanh Le, et al.
Published: (2023-06-01)
by: Duc Thanh Le, et al.
Published: (2023-06-01)
Nab-paclitaxel and gemcitabine plus camrelizumab and radiotherapy versus nab-paclitaxel and gemcitabine alone for locally advanced pancreatic adenocarcinoma: a prospective cohort study
by: Shuling Chen, et al.
Published: (2023-03-01)
by: Shuling Chen, et al.
Published: (2023-03-01)
Comparison between nab-paclitaxel and solvent-based taxanes as neoadjuvant therapy in breast cancer: a systematic review and meta-analysis
by: Miao Liu, et al.
Published: (2021-02-01)
by: Miao Liu, et al.
Published: (2021-02-01)
Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group
by: Thomas J. Ettrich, et al.
Published: (2018-12-01)
by: Thomas J. Ettrich, et al.
Published: (2018-12-01)
Comparison of Efficacy Between Nab-Paclitaxel or Docetaxel Combined with Carboplatin as Neoadjuvant Therapy for HER2-Positive Breast Cancer
by: Xin HAO, et al.
Published: (2024-09-01)
by: Xin HAO, et al.
Published: (2024-09-01)
Synchronous double primary malignancies of the pancreatic body and extrahepatic bile duct treated with pancreatoduodenectomy and splenic artery resection following neoadjuvant chemotherapy with gemcitabine plus nab-paclitaxel: a case report
by: Takahiro Murokawa, et al.
Published: (2022-02-01)
by: Takahiro Murokawa, et al.
Published: (2022-02-01)
Margin-negative minimally invasive pancreatoduodenectomy following FOLFIRINOX neoadjuvant chemotherapy in invasive intraductal papillary mucinous neoplasm of pancreas: a case report
by: Jinho Kim, et al.
Published: (2023-12-01)
by: Jinho Kim, et al.
Published: (2023-12-01)
A combination of paclitaxel and gemcitabine in an intensive dose-dense neoadjuvant chemotherapy schedule for locally advanced breast cancer
by: I. V. Frai, et al.
Published: (2014-08-01)
by: I. V. Frai, et al.
Published: (2014-08-01)
Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer
by: Annalisa Comandatore, et al.
Published: (2022-01-01)
by: Annalisa Comandatore, et al.
Published: (2022-01-01)
Efficacy and safety of weekly nab-paclitaxel plus gemcitabine in Chinese patients with metastatic adenocarcinoma of the pancreas: a phase II study
by: Ruihua Xu, et al.
Published: (2017-12-01)
by: Ruihua Xu, et al.
Published: (2017-12-01)
Chronic active Epstein–Barr virus and hydroa vacciniforme‐like lymphoproliferative disorder in a pediatric patient complicated by fatal ruptured cerebral artery aneurysm
by: Troy Yi, et al.
Published: (2023-06-01)
by: Troy Yi, et al.
Published: (2023-06-01)
Morphological, immunophenotypic and clinical characteristics of dogs with lymphocytic - plasmacytic duodenitis
by: Đorđević Milena, et al.
Published: (2012-01-01)
by: Đorđević Milena, et al.
Published: (2012-01-01)
Low‐dose gemcitabine plus nab‐paclitaxel versus standard‐dose gemcitabine plus nab‐paclitaxel in elderly patients with metastatic pancreatic cancer: A randomized Phase II trial
by: Ken Kamata, et al.
Published: (2023-09-01)
by: Ken Kamata, et al.
Published: (2023-09-01)
Intensified dose-dense neoadjuvant chemotherapy using paclitaxel-gemcitabine and docetaxel-doxorubicin combinations for locally advanced breast cancer
by: I. V. Frai, et al.
Published: (2014-07-01)
by: I. V. Frai, et al.
Published: (2014-07-01)
Neoadjuvant concurrent chemoradiotherapy using infusional gemcitabine in locally advanced rectal cancer: A phase II trial
by: Shouki Bazarbashi, et al.
Published: (2022-05-01)
by: Shouki Bazarbashi, et al.
Published: (2022-05-01)
Efficacy and Safety of Nab-Paclitaxel Plus S-1 versus Nab-Paclitaxel Plus Gemcitabine for First-Line Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma
by: Zong Y, et al.
Published: (2020-12-01)
by: Zong Y, et al.
Published: (2020-12-01)
Cost‐effectiveness of neoadjuvant FOLFIRINOX versus gemcitabine plus nab‐paclitaxel in borderline resectable/locally advanced pancreatic cancer patients
by: Myles A. Ingram, et al.
Published: (2022-09-01)
by: Myles A. Ingram, et al.
Published: (2022-09-01)
Nab-Paclitaxel plus gemcitabine in patients with metastatic pancreatic adenocarcinoma: experience of use
by: Elena Ferris Villanueva, et al.
Published: (2015-02-01)
by: Elena Ferris Villanueva, et al.
Published: (2015-02-01)
A case of metastatic NUT carcinoma with prolonged response on gemcitabine and nab‐paclitaxel
by: Shetal A. Patel, et al.
Published: (2021-08-01)
by: Shetal A. Patel, et al.
Published: (2021-08-01)
Modified gemcitabine plus nab‐paclitaxel regimen in advanced pancreatic ductal adenocarcinoma
by: Jane E. Rogers, et al.
Published: (2020-08-01)
by: Jane E. Rogers, et al.
Published: (2020-08-01)
Design of Covert Communication Waveform Based on Phase Randomization
by: Wenjie Zhou, et al.
Published: (2025-05-01)
by: Wenjie Zhou, et al.
Published: (2025-05-01)
THE EFFECT OF INTERNAL CONTROL ON CREDIT DISTRIBUTION EFFICIENCY
by: Anggiriawan P.B., et al.
Published: (2021-10-01)
by: Anggiriawan P.B., et al.
Published: (2021-10-01)
Hematopoietic Stem Cell Transplantation for the Treatment of Epstein-Barr Virus-Associated T- or NK-Cell Lymphoproliferative Diseases and Associated Disorders
by: Akihisa Sawada, et al.
Published: (2018-11-01)
by: Akihisa Sawada, et al.
Published: (2018-11-01)
De-escalated neoadjuvant nab-paclitaxel combined with pyrotinib and trastuzumab in intrinsic HER2-enriched breast cancer (NJMU-BC01): a multicenter, single-arm, phase 2 trialResearch in context
by: Hong Pan, et al.
Published: (2025-08-01)
by: Hong Pan, et al.
Published: (2025-08-01)
Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma
by: Daniel Herchenhorn, et al.
Published: (2007-10-01)
by: Daniel Herchenhorn, et al.
Published: (2007-10-01)
A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer
by: Kellie L. Bodeker, et al.
Published: (2024-11-01)
by: Kellie L. Bodeker, et al.
Published: (2024-11-01)
Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer
by: Cheng-Ke Xie, et al.
Published: (2024-09-01)
by: Cheng-Ke Xie, et al.
Published: (2024-09-01)
Assessment of neoadjuvant chemotherapy with docetaxel, cisplatin, and fluorouracil in patients with oral cavity cancer
by: Jin Ye Fu, et al.
Published: (2023-02-01)
by: Jin Ye Fu, et al.
Published: (2023-02-01)
First case report of neoadjuvant gemcitabine and S-1 for locally advanced unresectable duodenal adenocarcinoma
by: Jiro Kimura, et al.
Published: (2022-05-01)
by: Jiro Kimura, et al.
Published: (2022-05-01)
Comparison of Clinical Outcomes of Borderline Resectable Pancreatic Cancer According to the Neoadjuvant Chemo-Regimens: Gemcitabine versus FOLFIRINOX
by: Yoo Jin Choi, et al.
Published: (2021-05-01)
by: Yoo Jin Choi, et al.
Published: (2021-05-01)
Neoadjuvant therapy for sarcomatoid carcinoma of the pancreas: a case report and review of the literature
by: Hui Qiu, et al.
Published: (2023-07-01)
by: Hui Qiu, et al.
Published: (2023-07-01)
First successful laparoscopic pancreaticoduodenectomy in Bangladesh: Surgical procedure and operation outcome
by: Md Ismail Gazi, et al.
Published: (2024-12-01)
by: Md Ismail Gazi, et al.
Published: (2024-12-01)
Pemberdayaan Minat Kewirausahaan Masyarakat Sebagai Strategi Optimalisasi Penyaluran Kredit LPD Desa Adat Beraban
by: Ni Komang Urip Krisna Dewi, et al.
Published: (2024-08-01)
by: Ni Komang Urip Krisna Dewi, et al.
Published: (2024-08-01)
Similar Items
-
Camrelizumab Combined With Gemcitabine and Albumin-Bound Paclitaxel for Neoadjuvant Therapy in the Treatment of Progressive Gallbladder Cancer: A Case Report
by: Jing Wu, et al.
Published: (2022-03-01) -
Neoadjuvant‐modified FOLFIRINOX vs nab‐paclitaxel plus gemcitabine for borderline resectable or locally advanced pancreatic cancer patients who achieved surgical resection
by: Adam R. Wolfe, et al.
Published: (2020-07-01) -
Intensified Neoadjuvant Chemotherapy with Nab-Paclitaxel plus Gemcitabine Followed by FOLFIRINOX in a Patient with Locally Advanced Unresectable Pancreatic Cancer
by: Volker Kunzmann, et al.
Published: (2014-09-01) -
Impact of pathological complete response following neoadjuvant chemotherapy (gemcitabine, nab-paclitaxel, S-1) and radiation for borderline resectable pancreatic cancer: a case report and review of literature
by: Mitsuru Kinoshita, et al.
Published: (2022-09-01) -
The efficiency of liposomal paclitaxel versus docetaxel in neoadjuvant chemotherapy with the TPF regimen for locally advanced nasopharyngeal carcinoma: a retrospective study
by: Zhi Yang, et al.
Published: (2024-10-01)
